Bevacizumab for the treatment of surgically unresectable cervical cord hemangioblastoma: A case report

Journal of Medical Case Reports

Volumn 6, Issue , 2012, Pages

  Omar, Ayman I ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CAUCASIAN; CERVICAL SPINAL CORD; CLINICAL FEATURE; DRUG WITHDRAWAL; FOLLOW UP; HEMANGIOBLASTOMA; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUADRIPLEGIA; SPINAL CORD HEMANGIOBLASTOMA; TREATMENT OUTCOME; TUMOR REGRESSION;

EID: 84864822242     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-6-238     Document Type: Article

References (14)

1. Central nervous system capillary haemangioblastoma: the pathologist's viewpoint. Hussein MR, Int J Exp Pathol 2007 88 311 324 10.1111/j.1365-2613. 2007.00535.x 17877533
2. Expression of vascular endothelial growth factor in capillary hemangioblastoma. Morii K, Tanaka R, Washiyama K, Kumanishi T, Kuwano R, Biochem Biophys Res Commun 1993 194 749 755 10.1006/bbrc.1993.1885 7688226
3. Role of fractionated external beam radiotherapy in hemangioblastoma of the central nervous system. Koh ES, Nichol A, Millar BA, Ménard C, Pond G, Laperriere NJ, Int J Radiat Oncol Biol Phys 2007 69 1521 1526 10.1016/j.ijrobp.2007.05.025 17869023
4. Solid haemangioblastomas of the CNS: a review of 17 consecutive cases. Rachinger J, Buslei R, Prell J, Strauss C, Neurosurg Rev 2009 32 37 47 10.1007/s10143-008-0166-0 18810515
5. Stereotactic radiosurgical treatment of cranial and spinal hemangioblastomas. Moss JM, Choi CY, Adler JR, Soltys SG, Gibbs IC, Chang SD, Neurosurgery 2009 65 79 85 10.1227/01.NEU.0000348015.51685.D2 19574828
6. Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416. Schuch G, de Wit M, Höltje J, Laack E, Schilling G, Hossfeld DK, Fiedler W, Scigalla P, Jacobs MS, J Clin Oncol 2005 23 3624 3626 10.1200/JCO.2005.01.184 15908674
7. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Ferrara N, Hillan KJ, Novotny W, Biochem Biophys Res Commun 2005 333 328 335 10.1016/j.bbrc.2005.05.132 15961063
8. Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease. Sardi I, Sanzo M, Giordano F, Buccoliero AM, Mussa F, Aric M, Genitori L, Pediatr Blood Cancer 2009 53 464 467 10.1002/pbc.22065 19415739
9. Long-term use of intravitreal bevacizumab (avastin) for the treatment of von hippel-lindau associated retinal hemangioblastomas. Hrisomalos FN, Maturi RK, Pata V, Open Ophthalmol J 2010 4 66 69 21293730
10. Use of intravitreal bevacizumab in a patient with a Von Hippel-Lindau-associated retinal haemangioblastoma of the optic nerve head: a case report. de Klerk TA, Steel DH, J Med Case Reports 2008 29 182
11. von Hippel-Lindau disease. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH, Lancet 2003 361 2059 2067 10.1016/S0140-6736(03)13643-4 12814730
12. Identification of the von Hippel-Lindau disease tumor-suppressor gene. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Science 1993 260 1317 1320 10.1126/science.8493574 8493574
13. Spinal cord hemangioblastoma: diagnosis and clinical outcome after surgical treatment. Na JH, Kim HS, Eoh W, Kim JH, Kim JS, Kim ES, J Korean Neurosurg Soc 2007 42 436 440 10.3340/jkns.2007.42.6.436 19096585
14. Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Asthagiri AR, Mehta GU, Zach L, Li X, Butman JA, Camphausen KA, Lonser RR, Neuro Oncol 2010 12 80 86 10.1093/neuonc/nop018 20150370